|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1998-6-4
|
|
pubmed:abstractText |
To evaluate the toxicology and pharmacology of an orally active fluoropyrimidine given as a continuous daily dose divided into two portions for 6 weeks, and to determine the maximal-tolerated daily dose (MTD) and the suggested phase II daily dose.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1795-802
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9586893-Administration, Oral,
pubmed-meshheading:9586893-Adult,
pubmed-meshheading:9586893-Aged,
pubmed-meshheading:9586893-Antineoplastic Agents,
pubmed-meshheading:9586893-Deoxycytidine,
pubmed-meshheading:9586893-Drug Administration Schedule,
pubmed-meshheading:9586893-Female,
pubmed-meshheading:9586893-Fluorouracil,
pubmed-meshheading:9586893-Humans,
pubmed-meshheading:9586893-Male,
pubmed-meshheading:9586893-Middle Aged,
pubmed-meshheading:9586893-Neoplasms
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine.
|
|
pubmed:affiliation |
Department of Medicine, North Shore University Hospital, New York University Medical College, Manhasset 11030, USA. budman@nshs.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
